
|Slideshows|December 13, 2018
5 Classic Hallucinogens Studied in the Treatment of Addictions
Author(s)Michael P. Bogenschutz, MD
This slideshow provides information about the compounds, clinically relevant attributes, approximate dose, and data under study.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Positive Topline Results From Phase 3 Emerge Study of DT120 ODT in Major Depressive Disorder
2
FDA Issues CRL for Cytisinicline for Smoking Cessation in Adults
3
Psychiatric Pharmacogenomics: An Overview
4
Phase 2 Analysis of ML-004 for Autism Spectrum Disorder Fails to Meet Endpoint
5











